344 related articles for article (PubMed ID: 32778730)
1. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Lo R; Howard E; Hurrell BP; Galle-Treger L; Painter JD; Lewis G; Soroosh P; Sharpe AH; Akbari O
Nat Commun; 2020 Aug; 11(1):3998. PubMed ID: 32778730
[TBL] [Abstract][Full Text] [Related]
2. CD200-CD200R immune checkpoint engagement regulates ILC2 effector function and ameliorates lung inflammation in asthma.
Shafiei-Jahani P; Helou DG; Hurrell BP; Howard E; Quach C; Painter JD; Galle-Treger L; Li M; Loh YE; Akbari O
Nat Commun; 2021 May; 12(1):2526. PubMed ID: 33953190
[TBL] [Abstract][Full Text] [Related]
3. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity.
Thio CL; Lai AC; Chi PY; Webster G; Chang YJ
J Allergy Clin Immunol; 2019 Sep; 144(3):682-697.e9. PubMed ID: 30914379
[TBL] [Abstract][Full Text] [Related]
6. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.
LeSuer WE; Kienzl M; Ochkur SI; Schicho R; Doyle AD; Wright BL; Rank MA; Krupnick AS; Kita H; Jacobsen EA
J Allergy Clin Immunol; 2023 Aug; 152(2):469-485.e10. PubMed ID: 37028525
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma.
Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW
Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286
[TBL] [Abstract][Full Text] [Related]
8. Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity.
Sakano Y; Sakano K; Hurrell BP; Helou DG; Shafiei-Jahani P; Kazemi MH; Li X; Shen S; Hilser JR; Hartiala JA; Allayee H; Barbers R; Akbari O
J Allergy Clin Immunol; 2024 May; 153(5):1406-1422.e6. PubMed ID: 38244725
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity.
Galle-Treger L; Suzuki Y; Patel N; Sankaranarayanan I; Aron JL; Maazi H; Chen L; Akbari O
Nat Commun; 2016 Oct; 7():13202. PubMed ID: 27752043
[TBL] [Abstract][Full Text] [Related]
11. Small Proline-Rich Protein 3 Regulates IL-33/ILC2 Axis to Promote Allergic Airway Inflammation.
Zhu G; Cai H; Ye L; Mo Y; Zhu M; Zeng Y; Song X; Yang C; Gao X; Wang J; Jin M
Front Immunol; 2021; 12():758829. PubMed ID: 35126350
[TBL] [Abstract][Full Text] [Related]
12. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
13. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
14. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
15. Jiawei Yanghe Decoction attenuate allergic airway inflammation by suppressing group 2 innate lymphoid cells responses.
Wang Y; Cui J; Jiang Y; Zhang S; Chen L; Ma Z; Yang D; Zhang Z; Huang X; Yang Y; Guo J; Lu Z; Li C
J Ethnopharmacol; 2024 May; 326():117927. PubMed ID: 38373665
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma.
Aron JL; Akbari O
Allergy; 2017 Aug; 72(8):1148-1155. PubMed ID: 28160290
[TBL] [Abstract][Full Text] [Related]
17. CD52-targeted depletion by Alemtuzumab ameliorates allergic airway hyperreactivity and lung inflammation.
Shafiei-Jahani P; Helou DG; Hurrell BP; Galle-Treger L; Howard E; Quach C; Painter JD; Fung M; Lo R; Allayee H; Akbari O
Mucosal Immunol; 2021 Jul; 14(4):899-911. PubMed ID: 33731828
[TBL] [Abstract][Full Text] [Related]
18. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
19. T cells are the critical source of IL-4/IL-13 in a mouse model of allergic asthma.
Oeser K; Maxeiner J; Symowski C; Stassen M; Voehringer D
Allergy; 2015 Nov; 70(11):1440-9. PubMed ID: 26214396
[TBL] [Abstract][Full Text] [Related]
20. PD-1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator-activated receptor-γ.
Batyrova B; Luwaert F; Maravelia P; Miyabayashi Y; Vashist N; Stark JM; Soori SY; Tibbitt CA; Riese P; Coquet JM; Chambers BJ
Immun Inflamm Dis; 2020 Mar; 8(1):8-23. PubMed ID: 31742928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
